LNAI news

Lunai Bioworks received a determination that it no longer complies with a Nasdaq listing rule due to a shareholder deficit. The company intends to voluntarily delist its shares, suspending trading and its SEC reporting obligations.

Lunai Bioworks announced a multi-year revenue-generating defense collaboration with the U.S. government for AI-enabled chemical threat assessment and established partnerships with leading research institutions. The company is positioning its Augusta platform to align with national security prioritie…

Lunai Bioworks will execute a 1-for-8 reverse stock split to increase its stock price and regain Nasdaq compliance with minimum bid price requirements. The reverse split reduces outstanding shares from approximately 36.3 million to 4.5 million and follows a previous 1-for-10 reverse split in Septemb…